Piper Sandler has reiterated its 'Overweight' rating on Aflac and increased its price target from $138 to $143. This adjustment suggests a potential upside of 15.3% from the stock's recent closing price, indicating a moderately positive outlook from the analyst firm.
Piper Sandler maintained its 'Overweight' rating on Aflac and raised its price target to $143 from $138. This represents a 3.6% increase in the price target and implies a 15.3% upside from Aflac's closing price on November 6, 2026. This analyst action is a moderately positive signal for Aflac investors, as it reflects continued confidence in the company's future performance and valuation. While not a major catalyst, it could provide some short-term upward momentum for the stock. The long-term implications depend on Aflac's ability to meet or exceed the expectations embedded in this new price target. A key opportunity for traders is to consider this analyst upgrade as a potential indicator of positive sentiment in the insurance sector.